Hemostasis
Hemochron Signature Elite
Hemochron Signature Elite system standardizes ACT+, ACT-LR, PT and APTT testing at the point of care. Rapid, accurate and reproducible results, for patient management decisions in acute care settings, from the Cardiovascular Operating Room to the Cardiac Catherization Lab.
-
Rapid Whole Blood Hemostasis testing in acute care settings
-
Complete Assay Menu: ACT+, ACT-LR, PT, Citrate PT, APTT, Citrate APTT
-
Fast, accurate reproducible results for critical patient-management decisions. Simple, single-use, cartridge-based technology measures fibrin clot formation
-
To maximize efficiency and ensure regulatory compliance, automatic internal electronic Quality Control (EQC) with QC lockout, including cartridge and QC expiration, as well as operator tracking and lockout
Direct connection to Ethernet and major information systems. POCT-1A compliant.
​
-
Broadest test menú, ACT+ accurately measures heparin effects (1.0-6.0 u/mL blood); ACT-LR, sensitive to low heparin doses (0.0-2.5 u/mL blood), is the only low-range POC assay indicated for use during
​
-
Extracorporeal Life Support (ECLS), Percutaneous Coronary Intervention (PCI), vascular procedures, neurointerventional procedures, dialysis
​
-
PT/Citrate PT report INR with an effective INR range of 0.8-10.0 as well as whole blood seconds and plasma equivalent seconds. Our APTT and Citrate APTT report whole blood seconds and plasma equivalent seconds on samples containing heparin levels up to 1.5 U/mL
VerifyNow
The VerifyNow system offers platelet reactivity results in minutes, providing antiplatelet therapy guidance in many clinical settings, including the Operating Room, Cardiac Catheterization Lab, Interventional Radiology, as well as in the Lab.
The most cited and utilized platelet reactivity testing system, VerifyNow is an indispensable aid to optimizing patient outcomes.
-
Optimizes patient outcomes
VerifyNow Aspirin Test measures a patient's platelet response to Aspirin, while VerifyNow PRUTest helps identify patients responsive to antiplatelet therapy.
VerifyNow testing can measure antiplatelet effect prior to discharge, ensure drug response, identify risk for a related bleeding, thrombotic or major cardiac event, as well as non-compliance.